Proven results. Advanced science. A faster, more confident path to pregnancy.
Choosing an IVF centre is not only about choosing a clinic. It is about choosing the team, laboratory and technology that will handle your eggs, sperm and embryos at their most critical moments. At Genesis, part of Alpha IVF Group, every step is designed to maximise your chance of pregnancy through proven success rates, advanced reproductive science, precise laboratory systems and personalised care.
From fertility assessment to embryo transfer and follow-up care, our fertility specialists, embryologists, geneticists, nurses and patient coordinators work as one team – with one goal: to maximise your chances of having normal healthy babies.
Alpha IVF at a glance
| Why patients choose Alpha IVF | What this means for you |
| Proven, auditable success rates | Consistently very high pregnancy rates, comparable to leading IVF centres in the USA and Europe – documented, presented and supported by audit-ready clinical and laboratory data. |
| Alpha IVF’s proprietary System-of-Systems© | Alpha IVF’s success is not dependent on one technology alone. Our proprietary System-of-Systems© integrates hundreds of optimized clinical, laboratory and quality-control processes across the IVF program, helping every step work together with precision and consistency. |
| Faster time-to-pregnancy and better long-term value | By optimizing every stage — from ovarian stimulation and fertilization to embryo culture, selection, freezing and transfer — Alpha IVF aims to maximize the number of usable embryos from each egg retrieval. This may reduce the need for repeated stimulation cycles, shorten the time-to-pregnancy and improve the overall value of treatment. |
| Piezo-ICSI as standard since 2014 | An advanced fertilization technique that reduces mechanical stress to the egg. Alpha IVF data shows 83.1% fertilisation, 3.2% oocyte degeneration and 27% more usable blastocysts compared with conventional ICSI. |
| World-record post-warmed embryo survival | To the best of our knowledge, Alpha IVF has achieved a world record with 100.00% post-warmed embryo survival across 13,276 consecutive embryos, as at June 2026 (at the time of writing). |
| Comprehensive embryo selection | AI-assisted embryo selection and time-lapse monitoring help identify the embryo with the highest implantation potential for transfer. |
| PGT to reduce miscarriage risk | In-house PGT-A helps identify embryos with the correct number of chromosomes before transfer, reducing miscarriage risk caused by chromosomal abnormalities. |
| Innovation, experience and recognition | A team behind many world-first and regional-first achievements, more than 20,000 IVF babies, patients from 51+ countries, RTAC certification and multiple local and international awards. |
Important note: Individual IVF outcomes vary. Success rates should be interpreted together with age, ovarian reserve, sperm quality, embryo quality, uterine health, previous treatment history, genetic screening results and other medical factors.
1. Proven success rates that patients can trust
Alpha IVF has consistently achieved very high pregnancy rates comparable to leading IVF centres in the USA and Europe. We report success using Clinical Pregnancy Rate per Embryo Transfer, an internationally recognised and clinically meaningful measure that reflects the chance of pregnancy after an embryo has been transferred.
Our results are documented, presented and auditable. This gives patients confidence that Alpha IVF’s success is built on measurable performance, transparent reporting and continuous improvement – not unsupported marketing claims. While no IVF centre can guarantee pregnancy, proven and traceable outcomes matter.
2. Alpha IVF’s proprietary System-of-Systems©
At Alpha IVF, success is never determined by a single technology, procedure or person. Over more than a decade, we have developed and continuously refined our proprietary System-of-Systems© — an integrated approach that brings together every critical part of the IVF program.
This includes patient assessment, ovarian stimulation, egg collection, fertilization, embryo culture, embryo selection, cryopreservation, embryo transfer and follow-up care. Each step is carefully reviewed, optimized and supported by advanced technology, strict laboratory discipline, quality control and experienced clinical judgment.
For patients, this means your IVF program is not managed as isolated steps. It is managed as one coordinated system, where doctors, embryologists, geneticists, nurses and patient coordinators work together to protect every egg, every embryo and every opportunity for pregnancy.
3. Faster time-to-pregnancy and better long-term value
IVF value should not be measured only by the initial treatment cost. What matters most is how efficiently a centre can help patients achieve pregnancy with the fewest delays, repeat cycles and unnecessary procedures.
Through Alpha IVF’s System-of-Systems©, advanced laboratory technologies and personalised treatment planning, our goal is to maximize the number of usable embryos from each egg retrieval. More usable embryos can mean more transfer opportunities, fewer repeat stimulation cycles and a shorter time to pregnancy.
This is why Alpha IVF may offer stronger long-term value for patients. Even when the initial cost is not the lowest, a more efficient IVF journey may reduce the emotional, physical and financial burden of repeated treatment.
4. Piezo-ICSI as our standard fertilisation technique
Alpha IVF is the first IVF centres in Malaysia to have fully adopted Piezo-ICSI as the standard ICSI technique since 2014. Instead of forcefully piercing the egg membrane, Piezo-ICSI uses precise piezoelectric pulses to gently open the oocyte membrane and reduce mechanical stress to the egg.
Alpha IVF data presented in 2026 reported an 83.1% fertilisation rate compared with 69.6% for conventional ICSI, and a 3.2% oocyte degeneration rate compared with 7.3%. This translates into more fertilised eggs, less egg damage and, for many patients, 27% more usable blastocysts.
5. World-record embryo freezing and warming performance
Embryo freezing protects the embryos patients have worked so hard to create. To the best of our knowledge, Alpha IVF has achieved a world record with 100.00% post-warmed embryo survival across 13,276 consecutive embryos, as at June 2026 at the time of writing.
For patients, this means every frozen embryo is protected by a highly consistent cryopreservation program, helping preserve more opportunities for future frozen embryo transfer cycles.
6. AI-driven embryo selection to shorten time-to-pregnancy
Alpha IVF uses a comprehensive embryo selection system that combines AI-assisted embryo assessment, time-lapse monitoring, and expert embryologist review. This helps our team identify the embryo with the highest implantation potential for transfer, rather than relying on conventional embryo appearance alone.
AI-assisted embryo selection can help shorten time-to-pregnancy by supporting selection of the most viable embryo for the first embryo transfer. Published and presented work has reported a 13.8% reduction in time-to-pregnancy when AI is used to rank embryos for transfer. [1]
Alpha IVF has also been closely involved in AI-driven fertility innovation. In 2019, Alpha collaborated with the team that created the world’s first AI application for commercial use in IVF. [2] Alpha was also South-East Asia’s first centre to report a healthy live birth following transfer of an embryo selected using AI. [3]
More recently, Alpha IVF became the world’s first clinic to complete two independent blind validations of AI-powered oocyte spindle analysis using polarised light imaging to predict embryo chromosomal competence. This reinforces Alpha’s position as a centre that validates technology carefully before applying it responsibly in patient care.
7. In-house PGT for safer, more informed embryo transfer
Alpha IVF offers comprehensive in-house Preimplantation Genetic Testing (PGT) to provide deeper insight into embryo chromosomal and genetic health before transfer.
The primary benefit of PGT-A is to reduce miscarriage risk. PGT-A helps identify embryos with the correct number of chromosomes, allowing chromosomally normal embryos to be prioritised for transfer.
Alpha IVF also offers PGT-M for monogenic disorders, PGT-SR for structural chromosomal rearrangements and PGT-HLA for selected medical indications. With genetic testing closely integrated into the IVF laboratory, embryo selection becomes more efficient, personalized and clinically meaningful.
8. Complete fertility solutions under one roof
A successful fertility journey is not about offering more treatments – it is about recommending the right treatment at the right time. Alpha IVF provides a comprehensive fertility program within one coordinated system, covering advanced diagnostics, medical and surgical fertility treatment, IVF, fertility preservation, implantation optimisation, ovarian and endometrial optimisation, genetic testing and advanced reproductive technologies.
Because the full fertility pathway is available within the Alpha IVF ecosystem, our specialists can personalise each patient’s journey without compromise. Treatment is not determined by service limitations; it is determined by what is clinically appropriate for your diagnosis, goals and timeline.
9. World-first innovation, experienced people and internationally recognised care
Alpha IVF is not only a centre that adopts advanced technology – we help pioneer, validate and refine new frontiers in reproductive medicine. Our medical and scientific teams have been involved in many world-first, Asia-first, regional-first and national milestones across multiple areas of fertility care.
This culture of innovation is supported by experience. Alpha IVF Group doctors have helped couples from more than 51 countries and contributed to more than 20,000 IVF babies. Patients are supported by fertility specialists, embryologists, geneticists, nurses, counsellors and coordinators working together with one shared purpose.
Alpha IVF is also RTAC certified and has won many local and international awards for clinical quality, technology innovation, fertility outcomes, patient care and medical tourism excellence, including recognitions from HealthCare Asia, Global Health & Travel, Selangor Tourism Awards, Motherhood Choice Awards, The Asianparent Awards and Frost & Sullivan.
For patients, these achievements mean more than prestige. They reflect a centre built on advanced science, robust laboratory systems, personalised care and a team that treats every fertility journey with compassion, respect and professionalism.
